1. Home
  2. RVMD vs BG Comparison

RVMD vs BG Comparison

Compare RVMD & BG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

HOLD

Current Price

$152.16

Market Cap

19.2B

Sector

Health Care

ML Signal

HOLD

Logo Bunge Limited

BG

Bunge Limited

HOLD

Current Price

$119.13

Market Cap

24.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVMD
BG
Founded
2014
1818
Country
United States
United States
Employees
883
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
19.2B
24.9B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
RVMD
BG
Price
$152.16
$119.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
19
7
Target Price
$135.05
$132.29
AVG Volume (30 Days)
2.4M
1.5M
Earning Date
05-06-2026
04-29-2026
Dividend Yield
N/A
2.29%
EPS Growth
N/A
N/A
EPS
N/A
4.91
Revenue
N/A
$70,329,000,000.00
Revenue This Year
N/A
$36.19
Revenue Next Year
$411.49
$3.15
P/E Ratio
N/A
$24.94
Revenue Growth
N/A
32.43
52 Week Low
$34.00
$71.60
52 Week High
$148.00
$131.93

Technical Indicators

Market Signals
Indicator
RVMD
BG
Relative Strength Index (RSI) 87.60 41.00
Support Level $93.39 $116.69
Resistance Level N/A $126.62
Average True Range (ATR) 4.62 4.23
MACD 6.29 -1.03
Stochastic Oscillator 95.68 6.32

Price Performance

Historical Comparison
RVMD
BG

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

About BG Bunge Limited

Bunge Global SA is an agribusiness solutions company, connecting farmers to consumers and delivering essential food, feed and fuel to the globe. The company segments include Soybean Processing and Refining; Softseed Processing and Refining; Other Oilseeds Processing and Refining; Grain Merchandising and Milling; and Corporate and Other. It generates maximum revenue from the Soybean Processing and Refining segment, which includes integrated business principally involved in the purchase, storage, transportation, processing, distribution, refining, marketing, and sale of soybeans and soybean related products, as well as biodiesel and fertilizer production and distribution. Geographically, the company operates in United States, Switzerland, Netherlands, and Rest of the World.

Share on Social Networks: